Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function.

Pasquin S, Tormo A, Moreau J, Laplante V, Sharma M, Gauchat JF, Rafei M.

Front Immunol. 2019 Sep 10;10:2133. doi: 10.3389/fimmu.2019.02133. eCollection 2019.

2.

Cardiotrophin-like Cytokine Increases Macrophage-Foam Cell Transition.

Pasquin S, Laplante V, Kouadri S, Milasan A, Mayer G, Tormo AJ, Savin V, Sharma M, Martel C, Gauchat JF.

J Immunol. 2018 Oct 15;201(8):2462-2471. doi: 10.4049/jimmunol.1800733. Epub 2018 Sep 12.

3.

Effect of human very low-density lipoproteins on cardiotrophin-like cytokine factor 1 (CLCF1) activity.

Pasquin S, Chehboun S, Dejda A, Meliani Y, Savin V, Warner GJ, Bosse R, Tormo A, Mayer G, Sharma M, Sapieha P, Martel C, Gauchat JF.

Sci Rep. 2018 Mar 5;8(1):3990. doi: 10.1038/s41598-018-22400-y.

4.

Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: A multi-institutional prospective analysis.

Chicas-Sett R, Celada-Alvarez F, Roldan S, Rodriguez-Villalba S, Santos-Olias M, Soler-Catalan P, Ibanez-Rosello B, Arribas L, Tormo A, Benlloch JM, Perez-Calatayud J.

Brachytherapy. 2018 Jan - Feb;17(1):208-213. doi: 10.1016/j.brachy.2017.09.015. Epub 2017 Nov 4.

PMID:
29113782
5.

Bioinspired bright noniridescent photonic melanin supraballs.

Xiao M, Hu Z, Wang Z, Li Y, Tormo AD, Le Thomas N, Wang B, Gianneschi NC, Shawkey MD, Dhinojwala A.

Sci Adv. 2017 Sep 15;3(9):e1701151. doi: 10.1126/sciadv.1701151. eCollection 2017 Sep.

6.

Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.

Tormo A, Khodayarian F, Cui Y, Al-Chami E, Kanjarawi R, Noé B, Wang H, Rafei M.

J Hematol Oncol. 2017 Jun 14;10(1):120. doi: 10.1186/s13045-017-0490-3.

7.

High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late rectal toxicity.

Chicas-Sett R, Farga D, Perez-Calatayud MJ, Celada F, Roldan S, Fornes-Ferrer V, Ibanez-Rosello B, Tormo A, Benlloch JM, Perez-Calatayud J.

Brachytherapy. 2017 May - Jun;16(3):511-517. doi: 10.1016/j.brachy.2017.03.002. Epub 2017 Mar 31.

PMID:
28366276
8.

Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling.

Chehboun S, Labrecque-Carbonneau J, Pasquin S, Meliani Y, Meddah B, Ferlin W, Sharma M, Tormo A, Masson JF, Gauchat JF.

J Biol Chem. 2017 Apr 21;292(16):6644-6656. doi: 10.1074/jbc.M116.762021. Epub 2017 Mar 9.

9.

An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience.

Chicas-Sett R, Celada-Alvarez F, Roldán S, Torregrosa A, Betancourt J, Bautista-Ballesteros J, Farga D, Ibañez B, Tormo A, Perez-Calatayud J.

J Contemp Brachytherapy. 2016 Aug;8(4):349-55. doi: 10.5114/jcb.2016.61738. Epub 2016 Aug 16.

10.

Novel simple templates for reproducible positioning of skin applicators in brachytherapy.

Villalba SR, Perez-Calatayud MJ, Bautista JA, Carmona V, Celada F, Tormo A, García-Martinez T, Richart J, Ortega MS, Silla M, Ballester F, Perez-Calatayud J.

J Contemp Brachytherapy. 2016 Aug;8(4):344-8. doi: 10.5114/jcb.2016.61713. Epub 2016 Aug 9. Review.

11.

Intravascular Biphasic Synovial Sarcoma: The Beneficial Role of Adjuvant Treatment Approach in the Pre-metastatic Stage.

Chicas-Sett R, Farga-Albiol D, Collado E, Pacheco A, Zac C, Diaz R, Celada F, Burgos J, Perez MJ, Tormo A.

Cureus. 2016 Apr 16;8(4):e572. doi: 10.7759/cureus.572.

12.

Interleukin-21 administration to aged mice rejuvenates their peripheral T-cell pool by triggering de novo thymopoiesis.

Al-Chami E, Tormo A, Pasquin S, Kanjarawi R, Ziouani S, Rafei M.

Aging Cell. 2016 Apr;15(2):349-60. doi: 10.1111/acel.12440. Epub 2016 Jan 13.

13.

Therapeutic utility of the newly discovered properties of interleukin-21.

Al-Chami E, Tormo A, Khodayarian F, Rafei M.

Cytokine. 2016 Jun;82:33-7. doi: 10.1016/j.cyto.2015.12.018. Epub 2015 Dec 31. Review.

PMID:
26748727
14.

Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family.

Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A, Gauchat JF.

J Immunol Res. 2015;2015:714964. doi: 10.1155/2015/714964. Epub 2015 Jun 4.

15.

Fetal dose measurements and shielding efficiency assessment in a custom setup of (192)Ir brachytherapy for a pregnant woman with breast cancer.

Candela-Juan C, Gimeno-Olmos J, Pujades MC, Rivard MJ, Carmona V, Lliso F, Celada F, Ramírez-Coves JL, Ballester F, Tormo A, Perez-Calatayud J.

Phys Med. 2015 May;31(3):286-92. doi: 10.1016/j.ejmp.2015.01.010. Epub 2015 Feb 10.

PMID:
25681030
16.

Identification of olive pollen allergens using a fluorescence-based 2D multiplex method.

Zienkiewicz K, Alché Jde D, Zienkiewicz A, Tormo A, Castro AJ.

Electrophoresis. 2015 Apr;36(7-8):1043-50. doi: 10.1002/elps.201400508. Epub 2015 Mar 20.

PMID:
25640071
17.

Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes.

Tormo A, Celada F, Rodriguez S, Botella R, Ballesta A, Kasper M, Ouhib Z, Santos M, Perez-Calatayud J.

J Contemp Brachytherapy. 2014 Jun;6(2):167-72. doi: 10.5114/jcb.2014.43247. Epub 2014 Jun 3.

18.

Ex vivo generation of murine IL-10-producing B cells by fusokines.

Tormo A, Deng J, Al-Chami E, Ziouani S, Rafei M.

Methods Mol Biol. 2014;1190:115-25. doi: 10.1007/978-1-4939-1161-5_9.

PMID:
25015277
19.

Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.

Henríquez I, Sancho G, Hervás A, Guix B, Pera J, Gutierrez C, Abuchaibe O, Martínez-Monge R, Tormo A, Polo A.

Radiat Oncol. 2014 Apr 30;9:102. doi: 10.1186/1748-717X-9-102.

20.

A novel role for STAT5 in DC: Controlling the Th2-response.

Tormo AJ, Gauchat JF.

JAKSTAT. 2013 Oct 1;2(4):e25352. doi: 10.4161/jkst.25352. Epub 2013 Jun 10.

21.

The composite cytokine p28/cytokine-like factor 1 sustains B cell proliferation and promotes plasma cell differentiation.

Tormo AJ, Meliani Y, Beaupré LA, Sharma M, Fritz JH, Elson G, Crabé S, Gauchat JF.

J Immunol. 2013 Aug 15;191(4):1657-65. doi: 10.4049/jimmunol.1201595. Epub 2013 Jul 8.

22.

A polyglutamic acid motif confers IL-27 hydroxyapatite and bone-binding properties.

Tormo AJ, Beaupré LA, Elson G, Crabé S, Gauchat JF.

J Immunol. 2013 Mar 15;190(6):2931-7. doi: 10.4049/jimmunol.1201460. Epub 2013 Feb 6.

23.

The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.

Tormo AJ, Letellier MC, Lissilaa R, Batraville LA, Sharma M, Ferlin W, Elson G, Crabé S, Gauchat JF.

Cytokine. 2012 Dec;60(3):653-60. doi: 10.1016/j.cyto.2012.08.014. Epub 2012 Sep 15.

PMID:
22986012
24.

IL-6 activates STAT5 in T cells.

Tormo AJ, Letellier MC, Sharma M, Elson G, Crabé S, Gauchat JF.

Cytokine. 2012 Nov;60(2):575-82. doi: 10.1016/j.cyto.2012.07.002. Epub 2012 Jul 31.

PMID:
22854263
25.

Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience.

Díaz Beveridge R, Aparicio J, Tormo A, Estevan R, Artes J, Giménez A, Segura Á, Roldán S, Palasí R, Ramos D.

Clin Transl Oncol. 2012 Jun;14(6):471-80. doi: 10.1007/s12094-012-0826-y.

PMID:
22634537
26.

Impact of the Tiloop Bra® mesh in CT images and dose delivery in breast radiotherapy.

Camacho C, Pujades MC, Perez-Calatayud J, Lliso F, Carmona V, Tormo A, Ballester F.

J Appl Clin Med Phys. 2012 Mar 8;13(2):3667. doi: 10.1120/jacmp.v13i2.3667.

27.

Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation.

Massa F, Tormo A, Béraud-Dufour S, Coppola T, Mazella J.

Biochem Biophys Res Commun. 2011 Oct 14;414(1):118-22. doi: 10.1016/j.bbrc.2011.09.034. Epub 2011 Sep 14.

PMID:
21945442
28.

The use of nomograms in LDR-HDR prostate brachytherapy.

Pujades MC, Camacho C, Perez-Calatayud J, Richart J, Gimeno J, Lliso F, Carmona V, Ballester F, Crispín V, Rodríguez S, Tormo A.

J Contemp Brachytherapy. 2011 Sep;3(3):121-4. doi: 10.5114/jcb.2011.24817. Epub 2011 Sep 30.

29.

Multimodality management of a locally advanced primary oesophageal melanoma with radical surgery and adjuvant chemoimmunoradiotherapy.

Díaz R, Moral P, Fonfría M, de Juan M, Mancheño N, Tormo A.

Clin Transl Oncol. 2010 Apr;12(4):306-9. doi: 10.1007/s12094-010-0509-5.

PMID:
20462842
30.

Stationary phase in gram-negative bacteria.

Navarro Llorens JM, Tormo A, Martínez-García E.

FEMS Microbiol Rev. 2010 Jul;34(4):476-95. doi: 10.1111/j.1574-6976.2010.00213.x. Epub 2010 Feb 6. Review.

31.

Consensus on 3D treatment planning in gynaecologic brachytherapy of the Radiation Oncology Spanish Society (SEOR) Brachytherapy Group.

Guinot JL, Pérez-Calatayud J, Rodríguez S, Tormo A, Crispán V, Menéndez JC; Brachytherapy Spanish Group.

Clin Transl Oncol. 2010 Mar;12(3):181-7. Review.

PMID:
20231123
32.

Long-term results of neoadjuvant chemotherapy and combined chemoradiotherapy before surgery in the management of locally advanced oesophageal cancer: a single-centre experience.

Díaz R, Reynes G, Tormo A, de Juan M, Gironés R, Segura A, Aparicio J, Richart P, de la Cueva H, García J.

Clin Transl Oncol. 2009 Dec;11(12):835-41.

PMID:
20045790
33.

The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling.

Crabé S, Guay-Giroux A, Tormo AJ, Duluc D, Lissilaa R, Guilhot F, Mavoungou-Bigouagou U, Lefouili F, Cognet I, Ferlin W, Elson G, Jeannin P, Gauchat JF.

J Immunol. 2009 Dec 15;183(12):7692-702. doi: 10.4049/jimmunol.0901464.

34.

Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning.

Perez-Calatayud J, Kuipers F, Ballester F, Granero D, Richart J, Rodriguez S, Tormo A, Santos M.

Radiother Oncol. 2009 May;91(2):181-6. doi: 10.1016/j.radonc.2008.09.004. Epub 2008 Oct 22.

PMID:
18947893
35.

[Fever and cavitary infiltrate in a renal transplant recipient].

Rocamora N, Tormo AM, Franco A, Alvarez Avellán L, Olivares J.

Nefrologia. 2004;24 Suppl 3:16-20. Spanish.

36.

Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.

Fernández-Martos C, Aparicio J, Bosch C, Torregrosa M, Campos JM, Garcera S, Vicent JM, Maestu I, Climent MA, Mengual JL, Tormo A, Hernandez A, Estevan R, Richart JM, Viciano V, Uribe N, Campos J, Puchades R, Arlandis F, Almenar D.

J Clin Oncol. 2004 Aug 1;22(15):3016-22. Epub 2004 Jun 21.

PMID:
15210740
37.

GASP phenotype: presence in enterobacteria and independence of sigmaS in its acquisition.

Martínez-García E, Tormo A, Navarro-Lloréns JM.

FEMS Microbiol Lett. 2003 Aug 29;225(2):201-6.

38.

[Presence of hepatitis C virus in renal tissue in membranoproliferative glomerulonephritis and cryoglobulinemia].

Tormo A, Rivera F, Muñoz C, Trigueros M.

Nefrologia. 2003;23(2):165-8. Spanish.

39.

Polymorphism in the yclC-rpoS region of enterobacteria.

Martinez-Garcia E, Tormo A, Navarro-Lloréns JM.

Curr Microbiol. 2003 May;46(5):365-70.

PMID:
12732965
40.

Construction of a bacterial biosensor for styrene.

Alonso S, Navarro-Llorens JM, Tormo A, Perera J.

J Biotechnol. 2003 May 8;102(3):301-6.

PMID:
12730005
41.

Identification of an unknown promoter, OUTIIp, within the IS10R element.

Martínez-García E, Navarro-Lloréns JM, Tormo A.

J Bacteriol. 2003 Mar;185(6):2046-50.

42.

Enterobacter cloacae rpoS promoter and gene organization.

Navarro-Lloréns JM, Martínez-García E, Tormo A.

Arch Microbiol. 2002 Dec;179(1):33-41. Epub 2002 Oct 31.

PMID:
12471502
43.

An unusual cause of nephrotic syndrome and hypertension in a young woman.

Alvarez L, Ortega E, Rocamora N, Tormo A, Gil CM, Trigueros M, Rivera F.

Nephrol Dial Transplant. 2002 Nov;17(11):2026-9. No abstract available.

PMID:
12401868
44.

Further studies on RpoS in enterobacteria: identification of rpoS in Enterobacter cloacae and Kluyvera cryocrescens.

Martínez-García E, Tormo A, Navarro-Llorens JM.

Arch Microbiol. 2001 Jun;175(6):395-404.

PMID:
11491080
45.

Expression of the antifeeding gene anfA1 in Serratia entomophila requires rpoS.

Giddens SR, Tormo A, Mahanty HK.

Appl Environ Microbiol. 2000 Apr;66(4):1711-4.

46.

[Pre-operative radiotherapy, conventional or accelerated, for invasive bladder cancer. Objectives and radiation modalities. Results and complications].

López Torrecilla J, Tormo A, García-Miragall E, Rodríguez I, Solsona E, Petschen I.

Arch Esp Urol. 1999 Jul-Aug;52(6):586-94. Review. Spanish.

PMID:
10484842
47.

Role of the Escherichia coli SurA protein in stationary-phase survival.

Lazar SW, Almirón M, Tormo A, Kolter R.

J Bacteriol. 1998 Nov;180(21):5704-11.

48.

A consensus structure for sigma S-dependent promoters.

Espinosa-Urgel M, Chamizo C, Tormo A.

Mol Microbiol. 1996 Aug;21(3):657-9. No abstract available.

PMID:
8866487
49.

Sigma s regulates pLS1 maintenance in stationary-phase Escherichia coli.

Espinosa-Urgel M, Chamizo C, Tormo A.

FEMS Microbiol Lett. 1996 Jan 1;135(1):45-50.

PMID:
8598276
50.

VIP gene expression in rat thymus and spleen.

Gomariz RP, Delgado M, Naranjo JR, Mellström B, Tormo A, Mata F, Leceta J.

Brain Behav Immun. 1993 Dec;7(4):271-8.

PMID:
8280921

Supplemental Content

Support Center